GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » EV-to-EBIT

Sphere Medical Holding (LSE:SPHR) EV-to-EBIT : 0.52 (As of Jun. 12, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sphere Medical Holding's Enterprise Value is £-2.67 Mil. Sphere Medical Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 was £-5.14 Mil. Therefore, Sphere Medical Holding's EV-to-EBIT for today is 0.52.

The historical rank and industry rank for Sphere Medical Holding's EV-to-EBIT or its related term are showing as below:

LSE:SPHR' s EV-to-EBIT Range Over the Past 10 Years
Min: -2.6   Med: -0.3   Max: 1.6
Current: 0.52

During the past 9 years, the highest EV-to-EBIT of Sphere Medical Holding was 1.60. The lowest was -2.60. And the median was -0.30.

LSE:SPHR's EV-to-EBIT is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 19.69 vs LSE:SPHR: 0.52

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sphere Medical Holding's Enterprise Value for the quarter that ended in Dec. 2016 was £9.52 Mil. Sphere Medical Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 was £-5.14 Mil. Sphere Medical Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2016 was -54.02%.


Sphere Medical Holding EV-to-EBIT Historical Data

The historical data trend for Sphere Medical Holding's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding EV-to-EBIT Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only -2.64 -1.38 -1.73 -0.91 -1.85

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1.73 - -0.91 - -1.85

Competitive Comparison of Sphere Medical Holding's EV-to-EBIT

For the Medical Devices subindustry, Sphere Medical Holding's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's EV-to-EBIT falls into.



Sphere Medical Holding EV-to-EBIT Calculation

Sphere Medical Holding's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-2.674/-5.141
=0.52

Sphere Medical Holding's current Enterprise Value is £-2.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 was £-5.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding  (LSE:SPHR) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sphere Medical Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2016 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2016 ) =EBIT / Enterprise Value (Q: Dec. 2016 )
=-5.141/9.5174
=-54.02 %

Sphere Medical Holding's Enterprise Value for the quarter that ended in Dec. 2016 was £9.52 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 was £-5.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.